'Before Medically Advised' Discharge Linked to Risk for Overdose
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 23, 2024 -- 'Before medically advised' (BMA) discharge from the hospital is associated with an increased risk for subsequent drug overdose, according to a study published online Sept. 23 in CMAJ, the journal of the Canadian Medical Association.
Mayesha Khan, from the University of British Columbia in Vancouver, Canada, and colleagues conducted a retrospective cohort study using administrative health data from a 20 percent random sample of residents of British Columbia, Canada, to examine whether BMA discharge increases the risk for subsequent drug overdose. A survival analysis was used to compare the rate of fatal and nonfatal illicit drug overdose in the first 30 days after BMA discharge versus after physician-advised discharge.
Overall, 3.4 percent of the 189,808 hospital stays ended in BMA discharge. The researchers found that 92 percent of the 820 overdoses occurring in the first 30 days after any hospital discharge involved patients with a history of substance use disorder. The unadjusted overdose rates were 10-fold higher after BMA versus physician-advised discharge; even after adjustment for potential confounders, BMA discharge was associated with subsequent overdose (crude incidence, 2.8 versus 0.3 percent; adjusted hazard ratio, 1.58). Increases in subsequent emergency department visits and unplanned hospital readmissions were seen in association with BMA (adjusted hazard ratio, 1.92 and 2.07, respectively); no significant association was seen with fatal overdoses and all-cause mortality.
"Hospitals and health systems should develop evidence-based protocols to prevent BMA discharge and should explore novel means of postdeparture outreach to reduce the risk of drug overdose after hospital discharge," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-24 06:00
Read more
- U.S. Alcohol Intake Rose During Pandemic, and for Years After
- ACR: Colchicine No Benefit for Painful Knee Osteoarthritis
- Science Reveals Why Cancer Immunotherapies Can Sometimes Harm the Heart
- 80.5 Percent of Teens Experience at Least One Adverse Childhood Experience
- Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
- Childbirth Can Bring Worrying Medical Bills, Even With Insurance
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions